Highlighter is on. Drag to highlight text. Click a highlight to remove it.
ALL / Respiratory Medicine
Pneumonia: assessment and management
Pneumonia: assessment and management
Primary care setting
NICE recommends that patients should initially be assessed in primary care using the CRB65 criteria:
| Criterion | Marker |
|---|---|
| C | Confusion (abbreviated mental test score <= 8/10) |
| R | Respiration rate >= 30/min |
| B | Blood pressure: systolic <= 90 mmHg and/or diastolic <= 60 mmHg |
| 65 | Aged >= 65 years |
Patients are stratified for risk of death as follows:
- 0: low risk (less than 1% mortality risk)
- NICE recommend that treatment at home should be considered (alongside clinical judgement)
- 1 or 2: intermediate risk (1-10% mortality risk)
- NICE recommend that ' hospital assessment should be considered (particularly for people with a score of 2)'
- 3 or 4: high risk (more than 10% mortality risk)
- NICE recommend urgent admission to hospital
NICE also mention point-of-care CRP test. This is currently not widely available but they make the following recommendation with reference to the use of antibiotic therapy:
- CRP < 20 mg/L - do not routinely offer antibiotic therapy
- CRP 20 - 100 mg/L - consider a delayed antibiotic prescription
- CRP > 100 mg/L - offer antibiotic therapy
Secondary care setting
Note that in hospital, once blood tests are available the CURB65, rather than the CRB65, can be used. This adds an extra criterion of urea > 7 mmol/L:
| Criterion | Marker |
|---|---|
| C | Confusion (abbreviated mental test score <= 8/10) |
| U | urea > 7 mmol/L |
| R | Respiration rate >= 30/min |
| B | Blood pressure: systolic <= 90 mmHg and/or diastolic <= 60 mmHg |
| 65 | Aged >= 65 years |
NICE recommend, in conjunction with clinical judgement:
- consider home-based care for patients with a CURB65 score of 0 or 1 - low risk (less than 3% mortality risk)
- consider hospital-based care for patients with a CURB65 score of 2 or more - intermediate risk (3-15% mortality risk)
- consider intensive care assessment for patients with a CURB65 score of 3 or more - high risk (more than 15% mortality risk)
Investigations
- chest x-ray
- in intermediate or high-risk patients NICE recommend blood and sputum cultures, pneumococcal and legionella urinary antigen tests
- CRP monitoring is recommend for admitted patients to help determine response to treatment
Management of low-severity community acquired pneumonia
- amoxicillin is first-line
- if penicillin allergic then use a macrolide or tetracycline
- NICE now recommend a 5 day course of antibiotics for patients with low severity community acquired pneumonia
Management of moderate and high-severity community acquired pneumonia
- dual antibiotic therapy is recommended with amoxicillin and a macrolide
- a 7-10 day course is recommended
- NICE recommend considering a beta-lactamase stable penicillin such as co-amoxiclav, ceftriaxone or piperacillin with tazobactam and a macrolide in high-severity community acquired pneumonia
Discharge criteria and advice post-discharge
NICE recommend that patients are not routinely discharged if in the past 24 hours they have had 2 or more of the following findings:
- temperature higher than 37.5°C
- respiratory rate 24 breaths per minute or more
- heart rate over 100 beats per minute
- systolic blood pressure 90 mmHg or less
- oxygen saturation under 90% on room air
- abnormal mental status
- inability to eat without assistance.
They also recommend delaying discharge if the temperature is higher than 37.5°C.
NICE recommend that the following information is given to patients with pneumonia in terms of how quickly their symptoms should symptoms should resolve:
| Time | Progress |
|---|---|
| 1 week | Fever should have resolved |
| 4 weeks | Chest pain and sputum production should have substantially reduced |
| 6 weeks | Cough and breathlessness should have substantially reduced |
| 3 months | Most symptoms should have resolved but fatigue may still be present |
| 6 months | Most people will feel back to normal. |
All cases of pneumonia should have a repeat chest X-ray at 6 weeks after clinical resolution to ensure that the consolidation has resolved and there is no underlying secondary abnormalities (e.g. a lung tumour).
+PassMedicine Notes
Primary care setting
NICE recommends that patients should initially be assessed in primary care using the CRB65 criteria:
Criterion _ Marker| C _ Confusion (abbreviated mental test score = 30/min| B _ Blood pressure: systolic 100 mg/L - offer antibiotic therapySecondary care setting
Note that in hospital, once blood tests are available the CURB65, rather than the CRB65, can be used. This adds an extra criterion of urea > 7 mmol/L:
Criterion _ Marker| C _ Confusion (abbreviated mental test score 7 mmol/L| R _ Respiration rate >= 30/min| B _ Blood pressure: systolic